PCN38 A REAL WORLD EVIDENCE OF EFFECTIVENESS, SAFETY AND COST IMPLICATIONS OF TREATMENT REGIMENS IN MULTIPLE MYELOMA von Asrar, M., Bansal, D., Lad, D.P.

Volltext

PF498 A PHASE 2, RANDOMIZED, CONTROLLED, OPEN‐LABEL TRIAL OF DAILY VERSUS ALTERNATE DAY ORAL IRON IN TREATMENT OF IRON DEFICIENCY ANEMIA von Lad, D.P., Kaundal, R., Bhatia, P., Das, R., Jain, A., Nampoothiri, R., Mishra, K., Jandial, A., Jain, A., Goni, D., Sandal, R., Jindal, N., Meshram, A., Sharma, R., Khaire, N., Singh, C., Khadwal, A., Prakash, G., Suri, V., Varma, N., Varma, S., Malhotra, P.

Volltext

The effect of thromboxane a2 systhesis inhibitors on platelet aggregation in whole blood von Lad, N., Lunt, D.O., Tuffin, D.P.

Volltext

Inhibitory effect of a selective thromboxane A 2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo von Booth, R.F.G., Honey, A.C., Lad, N., Tuffin, D.P., Wade, P.J.

Volltext

The effect of thromboxane a 2 systhesis inhibitors on platelet aggregation in whole blood von Lad, N., Lunt, D.O., Tuffin, D.P.

Volltext

Effect of calcium and calcium antagonists on [ 3h]-paf-acether, binding to washed human platelets von Wade, P.J., Lunt, D.O., Lad, N., Tuffin, D.P., McCullagh, K.G.

Volltext

Interaction of the human platelet Paf-acether binding site with calcium and calcium channel antagonists von Wade, P.J., Lad, N., Tuffin, D.P.

Volltext

Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo von Booth, R.F.G., Honey, A.C., Lad, N., Tuffin, D.P., Wade, P.J.

Volltext